iHuman Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	807.02	922.2	1,018	985.52	944.72
Revenue Growth (YoY)	-12.49%	-9.42%	3.31%	4.32%	77.61%
Cost of Revenue	259.41	282.05	296.87	294.34	284.1
Gross Profit	547.61	640.15	721.27	691.17	660.62
Selling, General & Admin	272.41	333.96	319.09	283.96	318.57
Research & Development	208.44	234.28	242.29	295.63	396.3
Operating Expenses	480.85	568.24	561.38	579.59	714.87
Operating Income	66.76	71.91	159.89	111.58	-54.25
Other Non Operating Income (Expenses)	35.03	38.69	42.69	21.19	17.05
Pretax Income	101.79	110.6	202.57	132.77	-37.2
Income Tax Expense	6.39	12.01	21.67	22.95	-0.15
Net Income	95.4	98.59	180.91	109.82	-37.05
Net Income to Common	95.4	98.59	180.91	109.82	-37.05
Net Income Growth	-3.23%	-45.50%	64.73%	-	-
Shares Outstanding (Basic)	51	52	53	53	53
Shares Outstanding (Diluted)	54	54	55	54	53
Shares Change (YoY)	-1.32%	-0.94%	1.32%	1.34%	17.80%
EPS (Basic)	1.86	1.88	3.43	2.06	-0.69
EPS (Diluted)	1.80	1.80	3.30	2.05	-0.70
EPS Growth	0%	-45.45%	60.98%	-	-
Free Cash Flow	-	51.1	165.61	181.88	5.93
Free Cash Flow Per Share	-	0.94	3.02	3.37	0.11
Gross Margin	67.86%	69.42%	70.84%	70.13%	69.93%
Operating Margin	8.27%	7.80%	15.70%	11.32%	-5.74%
Profit Margin	11.82%	10.69%	17.77%	11.14%	-3.92%
Free Cash Flow Margin	-	5.54%	16.27%	18.45%	0.63%
EBITDA	80.41	85.57	171.58	122.41	-47.83
EBITDA Margin	9.96%	9.28%	16.85%	12.42%	-5.06%
D&A For EBITDA	13.66	13.66	11.69	10.83	6.42
EBIT	66.76	71.91	159.89	111.58	-54.25
EBIT Margin	8.27%	7.80%	15.70%	11.32%	-5.74%
Effective Tax Rate	6.28%	10.86%	10.70%	17.29%	-
Advertising Expenses	-	133.53	120.79	80.02	126.26

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q